Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough

Published 2019 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough
Authors
Keywords
Refractory chronic cough, P2X3R, Unexplained chronic cough
Journal
PULMONARY PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-03-15
DOI
10.1016/j.pupt.2019.03.006

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.